Compounds > sulochrin
Page last updated: 2024-09-04

sulochrin and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

sulochrin has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies

Compound Research Comparison

Studies
(sulochrin)		Trials
(sulochrin)		Recent Studies (post-2010)
(sulochrin)		Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
22079,156187552

Protein Interaction Comparison

ProteinTaxonomysulochrin (IC50)1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)
Platelet-activating factor receptorHomo sapiens (human)0.0003

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukamachi, H; Gleich, GJ; Ishikawa, M; Kawai, H; Kita, H; Miura, T; Motegi, Y; Ohashi, H1

Other Studies

1 other study(ies) available for sulochrin and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Sulochrin inhibits eosinophil activation and chemotaxis.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1998, Volume: 47, Issue:10

    Topics: Animals; Anti-Allergic Agents; Benzoates; Cell Degranulation; Chemotaxis, Leukocyte; Eosinophils; Guinea Pigs; Humans; Immunoglobulin A; Immunoglobulin G; Interleukin-8; Leukotriene B4; Leukotriene C4; Platelet Activating Factor; Sepharose; Superoxides

1998